Navigation Links
QIAGEN and Chittaranjan National Cancer Institute Partner to Establish First Large-Scale Cervical Cancer Screening Program in Kolkata
Date:4/20/2009

VENLO, Netherlands and KOLKATA, India, April 21 /PRNewswire-Asia/ -- QIAGEN and the Chittaranjan National Cancer Institute (CNCI) today announced a collaboration to establish the first large-scale cervical cancer screening program for women in Kolkata, India. QIAGEN (Nasdaq: QGEN; Frankfurt Prime Standard: QIA) will provide its diagnostic tests for the human papillomavirus (HPV) -- the primary cause of cervical cancer. CNCI will conduct the screening and provide appropriate treatment as needed.

The "QIAGENcares Kolkata Project" will use QIAGEN's hybrid capture 2 (hc2) HPV DNA testing technology (also known as the digene(R) HPV Test) to screen women for cancer-causing types of HPV to identify those with or at risk for developing cervical cancer. Participating women will also be screened using VIA (visual inspection with acetic acid) as per the Indian National Guidelines for Cervical Screening. Screening will take place at community-based mobile field clinics in the villages neighboring Kolkata. Women found to have cervical cancer or pre-cancer will be immediately treated at the field clinic -- a process referred to as "screen and treat" -- or referred to the CNCI for follow up. The project also includes educational campaigns to raise awareness about HPV, cervical cancer, and other women's health issues. The initiative will be conducted over 5 years and is expected to reach 50,000 women.

Despite being a preventable cancer with a known primary cause, cervical cancer claims nearly 300,000 lives every year -- with 80% of these deaths occurring in developing countries. India has more cervical cancer cases than any other country in the world. The World Health Organization (WHO) estimates that every year more than 130,000 Indian women are diagnosed with cervical cancer and more than 74,000 die from it. This makes ce
'/>"/>

SOURCE QIAGEN; Chittaranjan National Cancer Institute
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. QIAGEN N.V. (Nasdaq: QGEN) Invites You to Join Its Fourth Quarter and Year End 2007 Earnings and 2008 Guidance Conference Call on the Web
2. Webcast Alert: QIAGEN N.V. Announces First Quarter 2008 Earnings Conference Call
3. Webcast of QIAGEN N.V.s (Nasdaq: QGEN) Second Quarter 2008 Financial Results Call Set for August 5
4. SciQuest Announces Strategic Alliance with QIAGEN
5. QIAGEN Welcomes 3,000th Employee in 20th year of U.S. Operations
6. Webcast of QIAGEN N.V.s (Nasdaq: QGEN) Fourth Quarter and Year-End 2008 Financial Results Call Set for February 10
7. Brazilian National Biosafety Technical Committee Approves Monsanto Company Insect-Protected Corn Trait
8. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
9. Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
10. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
11. The Government of Quebec and the New Canadian Government Invest in the Creation of an International Biobank
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... ... July 29, 2015 , ... Brady ... GHS Label Guide . To align chemical container labeling with OSHA’s updated ... explanations of label components, an example of an accurate label, and pictogram uses ...
(Date:7/29/2015)... YORK , July 29, 2015  Therapath ... testing, announces increased partnerships with VA and Military ... Epidermal Nerve Fiber Density (ENFD) and Sweat Gland ... small fiber neuropathy ( https://therapath.com/skin ). ... Nerve Fiber Density (ENFD) on punch skin biopsy ...
(Date:7/29/2015)... SLOUGH, England , July 29, 2015  Indivior ... Application (NDA) for naloxone nasal spray was accepted and ... Administration (FDA) for the treatment of opioid overdose. This ... contains naloxone specially formulated for optimal absorption into the ... to require minimal training so individuals may be better ...
(Date:7/29/2015)... /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSX.V: ... to announce that the final design specifications of ... Prototypes for industrial and regulatory testing will now ... CE mark clearance to market the injector in ... (Photo: http://photos.prnewswire.com/prnh/20150729/248373 )  The ...
Breaking Biology Technology:Brady Announces a New GHS Label Guide 2Neuropathology services for VA and Military health systems 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 3Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 4Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 5RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 2RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 3RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 4RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype 5
... Delcath Systems, Inc. (Nasdaq: DCTH ), ... Perfusion ("PHP") System for the treatment of cancers of the ... 92) of patients have been enrolled in the Phase III ... liver. The eleven participating cancer centers in this trial ...
... India, December 11 , - SCRIP Awards Recognises ... and Biotech Industries Worldwide, - Glenmark is ... Prestigious Recognition, , ... at a glittering ceremony in London at the 2008 SCRIP Awards ...
... Board to Take Immediate Action to Protect and Maximize Shareholder Value ... Biotechnology Value Fund, L.P., the owner, together with its affiliates, of ... Inc. (Nasdaq: AVGN ) announced today that it had ... with Avigen,s recent performance and continued destruction of shareholder value. ...
Cached Biology Technology:Enrollment in Delcath's Pivotal Phase III Metastatic Melanoma Clinical Trial Reaches Halfway Point 2Enrollment in Delcath's Pivotal Phase III Metastatic Melanoma Clinical Trial Reaches Halfway Point 3SCRIP, the Leading Pharmaceutical Magazine in the World Crowns Glenmark as the "Best Pharma Company in the World - SME" and the "Best Company in Emerging Markets" at the SCRIP Awards 2008 in London 2Biotechnology Value Fund Delivers Letter to Board of Directors of Avigen, Inc. 2Biotechnology Value Fund Delivers Letter to Board of Directors of Avigen, Inc. 3Biotechnology Value Fund Delivers Letter to Board of Directors of Avigen, Inc. 4Biotechnology Value Fund Delivers Letter to Board of Directors of Avigen, Inc. 5
(Date:7/31/2015)... SHENZHEN , Kina, 31. juli 2015 ... ) bliver afholdt af BGI fra den 22. - 25. ... Konferencen fejrer sin 10-års fødselsdag i år. ... verdens mest indflydelsesrige årlige møder på ,omik,-feltet, og er ... forsamlinger. ICG-10 fokuserer på nylige gennembrud ...
(Date:7/31/2015)... , 31 de julio de 2015 BGI llevará ... www.icg-10.org ) del 22 al 25 de octubre de ... La conferencia celebra su décimo aniversario este año. ... en una de las reuniones anuales más influyentes del ... una de las conferencias científicas más dinámicas, entusiastas y ...
(Date:7/31/2015)... 31 de julho de 2015 A 10 ... ) será realizada pela BGI de 22-25 de outubro de ... A conferência está celebrando seu 10 o. ... ICG se tornou uma das reuniões mais influentes do ... científicos mais dinâmicos, entusiastas e prazerosos. ...
Breaking Biology News(10 mins):Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 3
... tell us a lot about the way species evolve after ... exceptionally broad study conducted in part by Florida State University ... the evolutionary history of rodents calls into doubt a generally ... such as a continent, evolution leads to a dramatic increase ...
... A new study shows that immune cells outside the ... presented today at the American College of Neuropsychopharmacology (ACNP) Annual ... impact on the quality of life, health and life expectancy ... of the disorder remain something of a mystery. In ...
... between genes and the environment has been pondered at least ... mid-1800s. But until the arrival of modern genomic sequencing ... environment had on a species, genetic makeup. Now, researchers ... flies that live on opposite slopes of a unique natural ...
Cached Biology News:Study of rodent family tree puts brakes on commonly held understanding of evolution 2Study of rodent family tree puts brakes on commonly held understanding of evolution 3Peripheral immune system may regulate vulnerability to depression 2Environment drives genetics in 'Evolution Canyon'; discovery sheds light on climate change 2Environment drives genetics in 'Evolution Canyon'; discovery sheds light on climate change 3
Oxidative Stress-Inducible Protein Tyrosine Phosphatase...
... Anti-MAGE-D2/NRAGE-Like 2b GenBank ... Immunogen : peptide (C-QSQENQDTRPKVKAKK), corresponding ... human MAGE-D2/NRAGE-Like 2b Formulation: antiserum ... 30% glycerol Quality Assurance: routinely ...
Antibody specific for histone H3 acetylated at any of the five N-terminal lysine residues. Rabbit polyclonal serum. Antigen: Synthetic peptide derived from histone H3 N-terminal region, mulitpliy...
The FailSafe™ PROBES Real-Time PCR System enables rapid, precise optimization of PCR experiments in which the product is detected using fluorescent target-specific labeled probes....
Biology Products: